.
Health Care

Defense Digest

COVID-19 and Florida’s Health Care Provider Liability Protection

Defense Digest, Vol. 27, No. 3, June 2021

June 1, 2021

by Megan J. Nelson

Key Points:

  • Florida Statute 768.38 and Florida Statute 768.381 offer liability protection for health care providers against claims related to COVID-19.
  • In order for the immunity to apply to a health care provider, the complaint must state the damages, injuries or death were related to COVID-19.
  • An affirmative defense that may apply to COVID-19-related claims against a health care provider is substantial compliance with government-issued health standards specifically related to COVID-19 when the injury occurred.

The coronavirus was first detected in Florida on March 1, 2020, and from its start, health care providers and facilities have been overrun with sick patients and limited supplies. At the beginning of the pandemic, multiple health care organizations provided guidance on how to properly manage patients during the crisis. Hospitals, nursing homes, assisted living facilities, and doctor’s offices were running low on supplies, and many patients were dying from COVID-19. More than a year has passed since the pandemic began, and Florida is being overrun with lawsuits against health care providers and facilities for claims associated to damages, injuries and deaths related to COVID-19. On March 29, 2021, Florida Governor, Ron DeSantis, signed CS/SB into law, creating Florida Statute 768.38 and Florida Statute 768.381, which offer liability protection for health care providers against claims related to COVID-19.

Florida Statute 768.381 provides liability protection for health care providers, including hospitals, nursing homes and assisted living facilities, against claims brought by a patient (or legal representative) related to damages, injuries or death due to COVID-19.

The liability protection for COVID-19-related claims against a health care provider mainly relates to claims arising from the diagnosis or treatment of a person for COVID-19, the provision of a novel or experimental COVID-19 treatment, the transmission of COVID-19, and the delay or cancellation of a surgery or medical procedure.

The new law will apply retroactively. A plaintiff will have one year from the time the injury related to COVID-19 occurred to bring a lawsuit. However, if a lawsuit for a cause of action related to COVID-19 were filed before March 29, 2021, the liability protection would not apply.

A plaintiff will still be required to participate in Chapter 766 pre-suit investigation. The liability protection will not be addressed until a complaint has been filed. For the liability protection to apply to a health care provider, the complaint must be pled with particularity. Meaning, the complaint must state that the damage, injury or death was related to COVID-19 and was caused by the health care provider’s acts or omissions.

There has been a recent surge in COVID-19 lawsuits, and plaintiffs have become creative in the language contained in their complaints. The language may claim an injury or death caused by a health care provider’s negligence related to COVID-19 without using the term COVID-19. For example, instead of the complaint stating the plaintiff died due to contracting COVID-19, the complaint will state the plaintiff died due to contracting a respiratory illness that eventually led to multi-organ failure.

Currently throughout the United States, cases related to COVID-19 injuries and death have been moved to federal court. This is due to the federal government allowing the COVID-19 pandemic to fall under the PREP Act. The PREP Act grants liability immunity to entities and individuals involved in developing, manufacturing, testing, distribution, administration and use of medical countermeasures. As the COVID-19 pandemic continued, seven amendments have been made to the PREP Act related to the medical countermeasures and who qualifies for immunity as a covered person. Health care providers and facilities have been identified as a covered person. With each amendment, the definition and qualification of a covered person have become more defined.

Once these cases are moved from state court to federal court, the judges must determine if the complaint was pled with particularity to include a cause of action related to COVID-19. The majority of federal courts have determined that the complaints do not include the specific language regarding COVID-19-related claims. Since the complaints do not specifically state a claim related to COVID-19, the health care provider does not qualify for immunity under the PREP Act. Therefore, the cases are sent back to the corresponding state court to be tried under that state’s medical negligence standard.

Florida has joined ranks with other states to combat these lawsuits and provide liability immunity to health care providers. Although Florida has passed a new law that gives liability immunity to health care providers and facilities, it is not an instant immunity. A complaint must still be filed, and the plaintiff must prove that the health care provider was negligent. However, if the health care provider can prove that they followed the guidance and standards from health care organizations, federal agencies or Florida agencies at the time of the incident, then immunity will apply.

The burden of proof that the plaintiff must prove is by the greater weight of the evidence. The plaintiff must prove more than just medical negligence. They must prove that the health care provider was grossly negligent or engaged in intentional misconduct. This means that the health care provider’s conduct must have been deliberate or committed with reckless disregard for the patient’s safety.

Even with this new law, in order for the immunity to apply to a health care provider, the complaint must state the damages, injuries or death was related to COVID-19. If the complaint states the medical negligence was related to anything other than COVID-19, the liability protection may not apply.

However, if the damage, injury or death is related to COVID-19 (e.g., medical diagnosis of COVID-19, positive COVID-19 respiratory swab, death certificate states cause of death was COVID-19), the health care provider should state the liability protection in the affirmative defenses. The new law provides additional affirmative defenses a health care provider should use.

The affirmative defenses that may apply to COVID-19-related claims against a health care provider include substantial compliance with government-issued health standards specifically related to COVID-19 when the injury occurred. This includes the early standards related to preserving or prioritizing supplies, materials or equipment due to widespread shortages of those necessary items.

Since the pandemic began, federal and state health care agencies have performed unannounced facility investigations to verify proper compliance with recommended health standards. Those certificates of compliance will be essential in proving that the facilities were making a good faith effort and substantially complied with the appropriate health standards at that time.

It will be essential to talk with your attorney regarding your facility’s compliance with the health care standards as soon as the pre-suit investigation begins. Although the court will not have a pre-suit hearing on health care liability protection related to COVID-19, it will help determine the strategy for the defense of your case.

*Megan is an associate in our Orlando, Florida office. She can be reached at 407.420.4381 or mjnelson@mdwcg.com.

Defense Digest, Vol. 27, No. 3, June 2021 is prepared by Marshall Dennehey Warner Coleman & Goggin to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2021 Marshall Dennehey Warner Coleman & Goggin. All Rights Reserved. This article may not be reprinted without the express written permission of our firm. For reprints, contact tamontemuro@mdwcg.com.

Firm Highlights

Thought Leadership

SIU Gets a Boost: NJ Supreme Court Affirms Insurers' Right to Litigate, Not Arbitrate, Fraud Claims

In a significant win for insurers' Special Investigation Units, the New Jersey Supreme Court clarified that statutory insurance fraud and racketeering claims may proceed in court rather than through PIP arbitration. At issue was whether insurance fraud claims brought under New Jersey's Insurance Fraud Prevention Act (IFPA) and the state's Anti-Racketeering Act (NJ RICO) are subject to mandatory arbitration under the Automobile Insurance Cost Reduction Act’s (AICRA) PIP dispute-resolution framework. Allstate had sued a network of medical practices, physicians, and related corporate entities, alleging a scheme to extract more than $1.7 million in PIP benefits through fraudulent and misleading billing. The trial court dismissed Allstate's complaint and compelled arbitration, reading AICRA's arbitration clause — which covers "any dispute regarding the recovery of... benefits" under PIP coverage, N.J.S.A. 39:6A-5.1(a) — as sweeping in fraud and racketeering claims along with routine benefit disputes. The Supreme Court affirmed the Appellate Division's reversal, adopting Judge Gilson's opinion below (480 N.J. Super. 566 (App. Div. 2025)) as its own reasoning. The Court held that IFPA and RICO claims fall outside the scope of AICRA's PIP arbitration mechanism because that "streamlined and specialized" process cannot grant the relief those statutes contemplate — treble damages, injunctive relief, broad discovery, and joinder of third parties — and because arbitrators lack authority to award compensatory or treble damages to an insurer. The Court also rejected the argument that Allstate's own Decision Point Review Plans independently compel arbitration, finding those plan provisions no broader than AICRA's own arbitration clause. Notably, the Court expressly disagreed with the Third Circuit's contrary holding in GEICO v. Mt. Prospect Chiropractic Center, 98 F.4th 463 (3d Cir. 2024), concluding it is not bound by that federal interpretation of New Jersey law. Insurers retain the right to pursue IFPA and RICO claims in the Law Division, with a jury trial. For SIU units and NJ insurance carriers, this decision is a significant win: it forecloses defense clinics' primary procedural tool for shunting fraud investigations into limited-scope PIP arbitration, where treble damages, RICO relief, and meaningful discovery were never realistically available. Carriers building cases against fraudulently structured clinics, straw-owned practices, or coordinated billing networks can now proceed with confidence that a well-pleaded IFPA/RICO complaint stays in the Law Division rather than being diverted to arbitration on a motion to compel. Practically, this strengthens SIU's leverage in settlement negotiations, preserves civil discovery tools (subpoenas, depositions, joinder of related corporate entities) critical to unwinding complex ownership and referral schemes, and resolves the split with the Third Circuit in favor of NJ insurers — at least as a matter of state law. Expect increased reliance on IFPA civil actions, rather than PIP arbitration demands, as SIU's primary enforcement vehicle going forward.

Portrait of Carolyn Schweizer, with text below: Philadelphia Office Managing Attorney

News

Marshall Dennehey Names Carolyn Schweizer New Philadelphia Office Managing Attorney

blue facade of a hospital sign against blue sky

Result

Defense Verdict in Complex Medical Malpractice Trial

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict. 

Result

Summary Judgment Secured, Preserving $750,000 in Coverage for Insured in Major Trucking Liability Dispute

Ray Freudiger and Michael A. Roberts (both of Cincinnati) successfully obtained summary judgment on behalf of their client in a coverage dispute arising from a May 19, 2022, motor vehicle accident. A permissive driver operated a box truck for an interstate trucking company and caused severe injuries to two tort victims. Prior to the accident, the insured had procured a commercial auto policy for the trucking company with stated limits of $1,000,000. Following the accident, the insurer initiated a declaratory judgment action asserting that only reduced bodily injury limits of $25,000/$50,000 applied and later counterclaimed, alleging it would not have insured the driver had he been properly submitted for approval under the policy. After extensive discovery, briefing, and oral argument, the court rejected the insurer’s attempt to shift responsibility for the $750,000 in coverage it was legally required to provide for permissive drivers under Ohio law, granting summary judgment in favor of the insured and preserving $750,000 in liability exposure.

Casey Alan Coyle Joins Marshall Dennehey's PA Appellate Practice as a Shareholder in Harrisburg and Philadelphia

News

Marshall Dennehey Expands Leading Pennsylvania Appellate Practice With Addition of Shareholder Casey Coyle

Thought Leadership

Congress Passes Financial Exploitation Prevention Act

On June 25, 2026, the House passed the Financial Exploitation Prevention Act of 2025 (“the Act”) by a vote of 414 to 2. The Act allows financial advisors and firms to delay suspicious transactions regarding the accounts of clients who are 65 or older, if they believe financial exploitation has occurred or is about to take place. With the advancement of technology and AI, the House’s overwhelming bipartisan passage of the Financial Exploitation Prevention Act represents an important step in strengthening the financial industry’s ability to combat the growing threat of elder financial exploitation. The Act recognizes what advisors have long known that financial professionals are often the first to detect suspicious behavior but have historically lacked clear legal authority to intervene before irreversible financial harm occurs. From the industry’s perspective, the bill accomplishes several important objectives, including the following: (1) Provides a practical “pause button” by allowing financial professionals to temporarily delay certain transaction requests when there is a reasonable belief that a senior or vulnerable adult is being financially exploited; (2) Empowers financial professionals to act by providing greater certainty that firms can act in good faith to protect clients without unnecessary legal risk; and (3) Strengthens investor protection without sacrificing client rights by allowing temporary delays based on a reasonable suspicion of exploitation, which is intended only to allow additional review and not to deny clients access to their money indefinitely. In sum, the Financial Exploitation Prevention Act will equip financial professionals with practical, carefully tailored tools to stop suspected financial exploitation before client assets are lost. By allowing firms to temporarily delay suspicious transactions under defined circumstances, Congress is recognizing the critical role advisors play as the first line of defense against increasingly sophisticated fraud schemes. The Act strikes an appropriate balance between protecting vulnerable investors and preserving individual financial autonomy, while reinforcing collaboration among advisors, families, and law enforcement to combat financial exploitation. The bill now awaits Senate action.

empty courtroom photo

Result

Summary Judgment Secured for Life Insurance Agent

Marshall Dennehey Announces 2026 Ohio Super Lawyers and Rising Stars

News

Marshall Dennehey Announces 2026 Ohio Super Lawyers and Rising Stars

Thought Leadership

New Jersey Expands Family Leave Protections Effective July 17, 2026

On January 17, 2026, Governor Murphy signed into law legislation expanding the New Jersey Family Leave Act (NJFLA). Beginning July 17, 2026, significant amendments to the NJFLA will expand job-protected family leave to smaller businesses and more employees across the state. The new law broadens coverage by lowering the threshold for private employers from 30 employees to 15 employees, meaning many smaller businesses will now be subject to the NJFLA. Employees of state and local government agencies will continue to be covered regardless of the size of the employer. The amendments also make it easier for employees to qualify for leave. Under the revised law, an employee will be eligible after three months of employment and at least 250 hours worked during the preceding 12 months, replacing the previous requirement of 12 months of employment and 1,000 hours worked. Currently, New Jersey's Temporary Disability Insurance (TDI) and Family Leave Insurance (FLI) programs provide eligible employees with wage replacement while they are on leave but do not independently guarantee job protection. The recent amendments to the New Jersey Family Leave Act (NJFLA) expand these protections by extending job-protected leave to additional employees. Under the amended law, employees receiving TDI or FLI benefits may be entitled to return to the same position they held before taking leave, or to an equivalent position with the same seniority, status, pay, and benefits. Although the legislation also states that it does not expand or modify an employee's reinstatement rights under the NJFLA, the amendments appear to provide job protection to eligible employees receiving TDI or FLI benefits without requiring them to separately satisfy the eligibility requirements of the NJFLA or the federal Family and Medical Leave Act (FMLA). As a result, some employees may be entitled to longer periods of job-protected leave than were previously available under existing law. With these amendments, New Jersey continues to strengthen workplace protections by expanding access to job-protected family leave for eligible employees. These changes significantly expand access to job-protected family leave and may require employers to update their leave policies, employee handbooks, and HR practices. Notably, employers who were previously not required to administer NJFLA may need to amend their policies and/or create new protocols to come into compliance with the NJFLA. Failure to do so would prove costly, as the penalties for non-compliance are significant.